Campello Elena, Zabeo Eva, Radu Claudia M, Spiezia Luca, Gavasso Sabrina, Fadin Mariangela, Woodhams Barry, Vettor Roberto, Simioni Paolo
Paolo Simioni, Department of Cardiologic, Thoracic and Vascular Sciences, and Department of Medicine, University of Padua, Via Ospedale Civile 105, 35100 Padua, Italy, Tel.: +39 049 8212667, Fax: +39 049 8212651, E-mail:
Thromb Haemost. 2015 Jan;113(1):85-96. doi: 10.1160/TH14-02-0156. Epub 2014 Oct 16.
The role of circulating microparticles (MP) of different origin and tissue factor (TF)-bearing in overweight and obese patients with and without metabolic syndrome is still a matter of debate. In a case-control study, the presence of hypercoagulability was evaluated in overweight and obese patients by measuring MP, thrombin generation (TG) and FVIIa-AT complexes. Twenty overweight patients (body mass index [BMI] range 25-29.9 kg/m²), 20 with I degree (30-34.9 kg/m²), 20 with II degree (35-39.9 kg/m²) and 20 with III degree obesity (≥ 40 kg/m²) were enrolled and compared to 40 age and gender-matched normal weight individuals. A significant increase in median levels of all MP subtypes was observed in the three degrees of obese patients compared to controls. Overweight patients had higher levels of annexin V-MP (AMP), endothelial-derived, leukocyte-derived and TF-bearing MP than controls. Obese patients had a significantly shorter median lag time (p< 0.05), higher median peak thrombin (p< 0.01) and increased median endogenous thrombin potential [ETP] (p< 0.001) compared to controls. Overweight subjects had significantly increased ETP compared to controls (p< 0.05). Both AMP levels and ETP were found to positively correlate with BMI, waist circumference, and inflammatory parameters. No significant increase in FVIIa-AT complex was seen in cases compared to controls. We conclude that obesity is associated with overproduction of procoagulant MP and increase TG. Interestingly, hypercoagulability is found in overweight patients free of metabolic syndrome and increases with the severity of obesity. Assessment of MP and TG may be helpful in the early characterisation of the prothrombotic state in obese patients.
不同来源且携带组织因子(TF)的循环微颗粒(MP)在伴有和不伴有代谢综合征的超重及肥胖患者中的作用仍存在争议。在一项病例对照研究中,通过测量MP、凝血酶生成(TG)和FVIIa-抗凝血酶(AT)复合物,评估超重和肥胖患者的高凝状态。纳入了20名超重患者(体重指数[BMI]范围为25 - 29.9 kg/m²)、20名I度肥胖患者(30 - 34.9 kg/m²)、20名II度肥胖患者(35 - 39.9 kg/m²)和20名III度肥胖患者(≥40 kg/m²),并与40名年龄和性别匹配的正常体重个体进行比较。与对照组相比,在三个肥胖程度组的患者中观察到所有MP亚型的中位数水平均显著升高。超重患者的膜联蛋白V-MP(AMP)、内皮来源、白细胞来源和携带TF的MP水平高于对照组。与对照组相比,肥胖患者的中位数延迟时间显著缩短(p<0.05),中位数凝血酶峰值更高(p<0.01),且中位数内源性凝血酶潜力[ETP]增加(p<0.001)。与对照组相比,超重受试者的ETP显著增加(p<0.05)。发现AMP水平和ETP均与BMI、腰围和炎症参数呈正相关。与对照组相比,病例组中FVIIa-AT复合物未见显著增加。我们得出结论,肥胖与促凝血MP的过度产生和TG增加有关。有趣的是,在无代谢综合征的超重患者中也发现了高凝状态,且随着肥胖程度的加重而增加。评估MP和TG可能有助于早期表征肥胖患者的血栓前状态。